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Abstract
Background: Atherosclerotic cardiovascular disease is the main cause of mortality in developed countries. It is a 
chronic and systemic inflammatory disease with a multifactorial etiology. Periodontal disease is one of the many 
factors that contribute to its development.
Objective: To analyze the effects of periodontal treatment on cardiovascular risk parameters in patients with ath-
erosclerotic cardiovascular disease.   
Material and Methods: A systematic research was conducted in the Pubmed/Medline databases for clinical trials 
published up to and including the year 2017. 
Results: Ten articles were included for analysis. Periodontal treatment reduced C-reactive protein levels (77.8% of 
clinical trials), tumor necrosis factor-alpha (66.7%), interleukin-6 (100%) and leukocytes (50%). Fibrinogen levels 
also improved considerably (66.7%). Effects on lipid parameters were more limited, whereby only oxidized low 
density lipoprotein and very low density lipoprotein cholesterol decreased significantly. Meta-analysis showed a 
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Introduction
Atherosclerotic cardiovascular disease (ACVD) consti-
tutes a group of chronic inflammatory pathologies that 
include ischemic heart disease, ischemic cerebrovascu-
lar disease, and peripheral arterial disease (1,2). It is the 
main cause of morbidity and mortality in industrialized 
countries, and of death in the world (1-3). The classic 
risk factors, such as hypercholesterolemia, hyperten-
sion, and smoking, only explain half the deaths of pa-
tients with this group of pathologies, and half of severe 
cardiovascular events (1,3). During the last 10 years, nu-
merous published studies have investigated the relation-
ship between ACVD and periodontal disease, because 
of the inflammatory basis that they share (1-7). How-
ever, research has not reached sufficiently certain con-
clusions to establish a causal relation between ACVD 
and periodontal disease. Nevertheless, on the basis of 
the information acquired to date, the potential positive 
effect of periodontal treatment on ACVD – if this can 
be confirmed – could constitute a new preventative/
therapeutic tool (3).
There is clear scientific evidence for the important role 
played by inflammation in the development of ACVD 
(2). Epidemiological studies support the association 
between periodontal disease and systemic inflamma-
tion (8,9) and various meta-analyses have identified a 
higher risk of developing cardiovascular disease among 
periodontal patients (10-14). However, the effect of peri-
odontal treatment on the atherosclerotic profile and the 
prevention of future cardiovascular events is not so clear 
(3,15). Analyzing the biochemical parameters consid-
ered cardiovascular risk factors can assess the impact 
of treatment. These can be grouped as inflammatory 
markers (C-reactive protein (CRP), tumor necrosis fac-
tor alpha (TNF-α), interleukin-6 (IL-6) and leukocytes), 
hemostatic or thrombotic markers, and lipid profile pa-
rameters (6).
In this context, the present systematic review was based 
on the following PICO question: P: periodontal treat-
ment; I: of patients with ACVD; C: compared with non-
treatment of periodontal disease; O: improvement to 
cardiovascular parameters.
Material and Methods
A literature search was conducted in the Pubmed da-
tabase with no limitations placed on publication date. 
The following key search terms were applied: “Car-
diovascular Disease” AND “Periodontal Treatment”; 
“Cardiovascular Disease” AND “Periodontal Thera-
py”; “Atherosclerosis” AND “Periodontal Treatment”; 
“Atherosclerosis” AND “Periodontal Therapy”; “Heart 
Disease” AND “Periodontal Therapy”; “Heart Disease” 
AND “Periodontal Treatment”; “Inflammatory Mark-
ers” AND “Periodontal Treatment”; and “Inflammatory 
Markers” AND “Periodontal Therapy”. 
The titles and abstracts of all the articles located were 
read to select clinical trials analyzing the effect of peri-
odontal treatment on the different clinical and biochem-
ical parameters related to ACVD. Works not written 
in English or Spanish were discarded, as were animal 
studies. Literature reviews and meta-analyses were also 
excluded, as well as clinical trials that assessed the ef-
fect of periodontal treatment on cardiovascular risk in 
patients with diabetes or metabolic syndrome. The full 
text was read in case of any doubt with regard to apply-
ing these selection/exclusion criteria. 
The complete texts of the selected articles were read, 
excluding any with patient ages below 18 years, or any 
that included patients without cardiovascular disease, 
even though the treatment applied or the parameters 
analyzed or objectives showed similarities to the other 
works selected for review. 
Due to the scarcity of articles that met the inclusion cri-
teria, studies were selected regardless of their method-
ology, the method of assigning treatment, sample size, 
follow-up period, or the clinical, biochemical or peri-
odontal parameters assessed.
The clinical trials included for review were assessed 
using the Critical Appraisal Skills Program CASPe 
(Spanish version) (16) and the review itself was assessed 
using the Preferred Reporting Items for Systematic Re-
views and Meta-Analyses (PRISMA) scale (17), with 20 
items.
Pooled estimates from the studies were analyzed using 
a continuous random-effects model meta-analysis. The 
statistically significant decreased in C-reactive protein and leukocytes values when patients were submitted to non-
surgical periodontal treatment in contrast to receiving no treatment at all (mean difference 1.199 mg/L, 95% confi-
dence interval: 1.100-1.299, p<0.001; and mean difference 0,79 g/L, 95% confidence interval: 0.717-0.879, p<0.001, 
respectively).
Conclusions: Periodontal treatment has a beneficial effect on some of the biochemical parameters considered to rep-
resent cardiovascular risk. Further randomized clinical trials are necessary, with longer follow-up periods including 
regular periodic monitoring, in order to determine the extent of the impact of periodontal treatment. 
Key words: Periodontal disease, cardiovascular disease, atherosclerosis, periodontal therapy, periodontal treatment.
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variable analyzed were changes produced in CRP and 
leukocytes under the following interventions: a) Oral 
hygiene instructions + Supragingival scaling + Root 
scaling and planing Vs. Oral hygiene instructions; b) 
Oral hygiene instructions + Supragingival scaling + 
Root scaling and planning Vs. Non treatment.
Forest plots were produced to graphically represent the 
difference in outcomes of CRP and leukocytes values. 
P = 0.05 was used as the level of significance. Het-
erogeneity was assessed with x2 test and I2 test. The 
OpenMeta[analyst] tool was employed in the statistical 
analysis.
Results
-Identified studies
Of the 192 articles initially located in the electronic 
search, 134 were discarded having read titles and ab-
stracts, as they did not fulfill the selection criteria. The 
full texts of the 58 remaining articles were read, exclud-
ing two works as they focused on patients aged younger 
than 18 years, and 46 other works centered on patients 
without cardiovascular disease. 
Following the selection process, the review analyzed a 
total of 10 clinical trials evaluating the effect of peri-
odontal treatment on clinical and biochemical param-
eters involved in the development of ACVD and/or per-
taining to patients diagnosed with ACVD aged over 18 
years. The total population included in the studies was 
669 patients (390 in intervention groups and 279 in con-
trol groups) (Fig. 1) (Tables 1, 1 continue,2).
With the exception of two of these studies (18,19), all of 
them excluded patients with any acute or chronic con-
ditions that could influence systemic inflammation and 
distort de results obtained.
-Periodontal treatment
The periodontal treatment performed in the studies re-
viewed consisted of mechanical debridement (n=390) 
(18-27) in all cases, complemented by oral hygiene 
instruction (OHI) in most of them (19,20,23). In other 
clinical trial periodontal pockets were reduced using a 
Fig. 1. Flow diagram of selection process for articles: 10 trials were selected for analysis.
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Author Study 
type
CASPe
N Sample Values regis-
tered
Periodontal 
parameters
Periodontal 
treatment
Follow-up Significant 
results
Hada et al. 
(2015) (20) RCT
7
55 
(CG=25; 
IG=30)
CG and 
IG: PD and 
CVD
HR, RR, AP, 
cyanosis, jugular 
vein pressure, 
edema, jaundice, 
finger clubbing, 
CRP, leukocytes, 
lymphocytes, 
neutrophils, TC, 
HDL-C, LDL-C, 
VLDL-C, TGs
Pd, BP, CIL, 
ID, GI
CG: OHI; 
IG: OHI + 
tartrectomy + 
SRP
0, 1, 3, 6 
months
↓ SAP, ↓ 
VLDL-C, 
↓ GI, ↓ PI, 
↓ PD and  ↓ 
BP after 6 
months
Offenbacher 
et al. (2009) 
(19)
RCT
8
37 
(CG=12; 
IG=25)
CG and 
IG: PD and 
CVD
CRP, IL-1b (in 
crevicular fluid)
PI, GI, SC, Pd, 
BP, CIL
CG: OHI; 
IG: OHI + 
tartrectomy + 
SRP
0, 6, 12 
months
↓ PD after 6 
months and 
↓ SC after 
12 months
Koppolu et al. 
(2013) (21)
RCT
9
39 
(CG=19; 
IG=20)
CG and 
IG: PD and 
CVD
CRP, TNF-α Pd, SOHI CG: nothing; 
IG: tartrec-
tomy + SRP
0, 2 months ↓ PD, ↓ 
SOHI, ↓ 
CRP and ↓ 
TNF-a
Bal et al. 
(2014) (22)
CT
6
50 
(CG1=13; 
CG2=13; 
IG1=11; 
IG2=13)
CG1: nei-
ther PD nor 
CVD; CG2: 
no 
PD yes 
CVD; IG1: 
yes PD no 
CVD; IG2: 
PD and 
CVD
Salivary and 
plasma Chitotrio-
sidase, salivary 
proteins 
PI, GI, Pd CG 1 and 2: 
nothing; IG 1 
and 2: OHI + 
tartrectomy + 
SRP + pocket 
debridement 
+ weekly 
sulcular CHX 
irrigation + 
adjoining 
restoration 
adjustment 
0, 5 weeks ↓ salivary 
chitotriosi-
dase, ↓ PI, 
↓ GI and 
↓ PD
Rastogi et al. 
(2012) (27)
CT
6
20
 (IG=20)
PD and 
CVD
CRP, TNF-a, 
leukocytes
Pd, BP IHO + tar-
trectomy + 
SRP
0, 1 month ↓ PD, ↓ BP, 
↓ CRP and 
↓ leuko-
cytes
Higashi et al. 
(2009) (18)
RCT
10
101
 (CG1: 24; 
CG2=53; 
IG=24)
CG1: PD 
and CVD; 
CG2: no PD 
yes CVD; 
IG: PD and 
CVD
AP, HR, TC, 
HDL-C, LDL-C, 
TGs, glucose, in-
sulin, IL-6, CRP, 
FBF response to 
ACh and SNP, 
MDA, 8-OHdG
BP, Pd, CIL CG 1 and 2: 
nothing; IG: 
OHI + SRP + 
antibiotics af-
ter intensive 
treatment  
0, 6 months ↓ CRP, ↓ 
IL-6, ↓ PD, 
↓ CIL, ↓ BP 
and  ↑ FBF 
response to 
Ach
Zhou et al. 
(2013) (24)
CT
8
75 
(CG=35; 
IG=40)
CG and 
IG: PD and 
CVD
CRP, TNF-a, IL-
6, glucose, TC, 
LDL-C, HDL-C, 
TGs, leukocytes
BI, PI, Pd, CAL CG: OHI; 
IG: OHI + 
tartrectomy + 
SRP
0, 3 months ↓ BI, ↓ 
PI, ↓PD, 
↓CAL, ↓ 
CRP, ↓ IL-
6, ↓ TNF-α 
y ↓ LDL-C
Table 1. Summary of the clinical studies reviewed.
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Abbreviations: 8-OHdG: 8-hydroxy-2’-deoxyguanosine; Ach: acetylcholine; AP: arterial pressure; BI: bleeding index; BP: bleeding on prob-
ing; CAL: clinical attachment loss; CASPe (16): critical appraisal skills program (Spanish version); CG: control group; CG1: control group 1; 
CG2: control group 2; CHX: chlorhexidine; CIL: clinical insertion level; CPSS: clinical periodontal sum score; CRP: C-reactive protein; CRSS: 
clinical and radiographic sum score; CT: clinical trial; CVD: cardiovascular disease; FBF: forearm blood flow; FD: furcation defects; FGN: 
fibrinogen; GI: gingival index; HDL-C: high density lipoprotein cholesterol; HR: heart rate; IG: intervention group;  IG1: intervention group 1; 
IG2: intervention group 2; IL-1ß: interleukin-1-beta; IL-6: interleukin -6; LDL-C: low density lipoprotein cholesterol; MDA: malondialdehyde; 
OHI: oral hygiene instruction; ox-LDL: oxidized LDL; PD: periodontal disease; Pd: probe depth; PI: plaque index; RCT: Randomized clinical 
trial; RR: respiratory rate; RVBL: radiological vertical bone loss; SAP: systolic arterial pressure; SC: subgingival calculus; SNP: sodium nitro-
prusside; SOHI: simplified oral hygiene index; SRP: scaling and root planing; SUP: suppuration on probing; TC: total cholesterol; TGs: triglyc-
erides; TNF-α: tumor necrosis factor alpha; VLDL-C: very low density lipoprotein cholesterol; vWF: von Willebrand factor. (#) All parameters 
were determined in each subject at baseline, after 4 months as a control and 3 months after an intensive protocol of scaling and root planning.
Table 1 continue. Summary of the clinical studies reviewed.
Bokhari et al. 
(2012) (25)
RCT
9
246
 (CG=85; 
IG=161)
CG and 
IG: PD and 
CVD
CRP, FGN, 
leukocytes
BP, Pd, CAL CG: nothing; 
IG: OHI + 
tartrectomy + 
SRP
0, 1, 2 
months
↓ BP, ↓ PD, 
↓ CRP and 
↓ leuko-
cytes after 
1 and 2 
months; ↓ 
FGN after 2 
months
Bokhari et al. 
(2009) (23)
CT
8
28 
(IG1=17; 
IG2=11)
IG1: PD and 
CVD; IG2: 
yes PD no 
CVD
CRP, FGN,
 leukocytes
Pd, BP IG 1 and 2: 
OHI + tar-
trectomy + 
SRP
0, 1 month ↓ PD, ↓ BP, 
↓CRP, ↓ 
FGN and↓ 
leukocytes
Montebugnoli 
et al. (2005) 
(26)
CT
9
18(#) 
(CG=IG=18)
PD and 
CVD
CRP, FGN, 
leukocytes, vWF, 
ox-LDL, dimer-D
CPSS (Pd, 
BP, SUP, FD), 
CRSS (FD, 
RVBL)
OHI + tar-
trectomy + 
SRP
0, 4 (control 
period), 7 
months (3 
months in-
tervention 
period)
↓ CPSS, ↓ 
CRSS, ↓ 
CRP and↓ 
ox-LDL
Hada et al. (2015) (20) Reduction in systolic blood pressure and very-low-density lipoproteins values.
Offenbacher et al. (2009) (19) No significant effect on serum C-reactive protein levels.
Koppolu et al. (2013) (21) Decreased values of C-reactive protein and tumor necrosis factor alpha.
Bal et al. (2014) (22) Reduction in salivary chitotriosidase activity.
Rastogi et al. (2012) (27) Decrease in C-reactive protein and white blood cells levels.
Higashi et al. (2009) (18) Reduction in C-reactive protein and interleukin-6 concentrations; increase in acetylcho-
line-induced vasodilation.
Zhou et al. (2013) (24) Improvement in tumor necrosis factor alpha, interleukin-6, C-reactive protein and low-
density lipoproteins-cholesterol values.
Bokhari et al. (2012) (25) Decrease in C-reactive protein, fibrinogen and white blood cells levels.
Bokhari et al. (2009) (23) Reduction in C-reactive protein, fibrinogen and white blood cells values.
Montebugnoli et al. (2005) (26) Improvement in C-reactive protein and oxidized-low density lipoprotein concentrations.
Table 2. Summary of main results.
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diamond bur (n=24) (22), and in another, antibiotic ther-
apy was used in some cases depending on the intensity 
of the treatment applied (n=24) (18).
Selected articles did not show homogeneity in the di-
agnosis of periodontal disease. In the vast majority the 
term chronic periodontitis was used without specifying 
the degree, with exception of one in which patients with 
chronic gingivitis and mild to moderate periodontitis 
were included (20).
-ACVD diagnosis
The criteria defining cardiovascular pathology differed 
from study to study. In some cases, patients with pre-
vious histories of cardiovascular events (n=94) (20,21) 
were included, in others, patients with obstruction over 
50% or over 70% in at least one artery (n=43) (22,23), 
or both (n=477) (18,19,24-26).  In one article, subjects 
had been diagnosed with coronary artery pathology, al-
though this was not specified in detail (n=20) (27).
-Periodontal parameters
The variables used to objectify improvement in peri-
odontal status in all the studies reviewed were: probe 
depth, bleeding on probing, and gingival index. Clini-
cal insertion level was measured in half the works 
(18-20,24,25). Follow-up periods ranged between one 
month and one year, with a mean of 15 weeks. 
-Cardiovascular parameters
Regarding the cardiovascular risk parameters assessed, 
nine works analyzed CRP, (18-21,23-27) observing 
significant reductions in CRP levels after periodontal 
treatment (n=311) (18,21,23-27). TNF-ß was studied in 
three of the trials (21,24,27), finding a statistically sig-
nificant reduction in two of them (n=60).(21,24) IL-6 
was only measured in two works (18,24) observing sig-
nificant reductions after periodontal treatment (n=64). 
IL-1α levels were only analyzed in a single work in cre-
vicular fluid samples, but did not present any significant 
improvement after periodontal treatment (19).
As for lipid profiles, three works (18,20,24) analyzed 
plasma levels of total cholesterol, LDL-C, HDL-C and 
triglycerides. None of them observed significant chang-
es in total cholesterol levels, HDL-C or triglycerides 
after periodontal treatment. Only one of them observed 
a significant reduction in LDL-C resulting from treat-
ment (n=40) (24). A study conducted on 18 patients 
measured oxidized LDL, obtaining a significant reduc-
tion in levels after treatment (n=18) (26). VLDL choles-
terol was only measured in one work,(20) also obtaining 
a significant reduction (n=30).
Total leukocyte levels were analyzed in six studies 
(20,23-27), observing significant reductions in three 
of them after periodontal treatment (n=209) (23,25,27). 
One of this clinical trials also measured lymphocyte 
and neutrophil levels individually, but did not observe 
any differences resulting from periodontal treatment 
(20). None of these six works included antibiotic ther-
apy in periodontal treatment. Two of the three studies 
(23,25,26) that studied fibrogenin observed significant 
reductions (n=189) (23,25). Glucose levels were mea-
sured in two studiesb (18,24) but neither saw any chang-
es. No significant changes were obtained regarding in-
sulin levels after periodontal treatment (18).
-Other parameters
One work evaluated salivary and plasma chitotriosidase 
(enzyme produce by activated macrophages) and sali-
vary proteins (22). After periodontal treatment, a sig-
nificant reduction in the salivary enzyme was observed 
(n=24), put not in plasma or in the salivary proteins 
evaluated. 
Another study (26) measured von Willebrand factor and 
fibrin D-dimer but did not observe significant differenc-
es after periodontal treatment.  
Other parameters analyzed in the studies were malond-
ialdehyde-modified LDL, 8-hydroxy-2’-deoxyguano-
sine, and forearm blood flow response to acetylcholine 
and sodium nitroprusside (18). After periodontal treat-
ment, significant changes were observed in blood flow 
response to acetylcholine, considerably increasing va-
sodilation (n=24).
Heart rate and blood pressure were analyzed in two of 
the works (18,20). The only significant result was a re-
duction in systolic blood pressure observed in the first 
study (n=30) (20). This one also analyzed other clinical 
parameters (respiratory rate, the presence of cyanosis, 
jugular venous pressure, edema, jaundice, and soft tis-
sue enlargement (clubbing) of the fingers) but no signifi-
cant changes were produced in any of these parameters 
after treatment. 
-CRP and leukocytes Meta-analysis
Separate meta-analysis was performed to analyze the 
mean differences of CRP between studies. Three stud-
ies (19,20,24) evaluated values of CRP before and af-
ter the administration of Oral hygiene instructions + 
Supragingival scaling + Scaling and root planning in 
the treatment group (n= 95) Vs. Oral hygiene instruc-
tions in the control group (n=72). The forest plot (Fig. 
2a) shows a CRP mean difference of 0.03mg/l and a p 
value = 0.966 (95% CI: -1.353 to 1.414, heterogeneity I2 
=0%, P=0.766).
Four studies (18,21,25,26) assessed values of CRP be-
fore and after the administration of Oral hygiene in-
structions + Supragingival scaling + Scaling and root 
planing in the treatment group (n= 223) Vs. Non treat-
ment in the control group (n=146). The forest plot (Fig. 
2b) shows a CRP mean difference of 1.199 mg/l and a 
p value = <0.001 (95% CI: 1.100 to 1.299, heterogeneity 
I2 =0%, P=0.918).
Also a meta-analysis was performed to analyze the 
mean differences of leukocytes between studies. Two 
studies (22,30) evaluated values of leukocytes before 
and after the administration of Oral hygiene instruc-
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Fig. 2. (a) Forest plot: studies evaluating CRP values before and after the administration of Oral hygiene instructions + Supragin-
gival scaling + Scaling and root planing in the treatment group Vs. Oral hygiene instructions in the control group. (b) Forest plot: 
studies evaluating CRP values before and after the administration of Oral hygiene instructions + Supragingival scaling + Scaling 
and root planing in the treatment group Vs. Non treatment.
tions + Supragingival scaling + Root scaling and plan-
ning in the treatment group (n= 70) Vs. Oral hygiene 
instructions in the control group (n=60). The forest plot 
(Fig. 3a) shows a leukocytes mean difference of 0.67 g/l 
and a p value = 0.158 (95% CI: -0.260 to 1.596, hetero-
geneity I2 =0%, P=0.321).
Two studies31,32 assessed values of leukocytes before 
and after the administration of Oral hygiene instruc-
tions + Supragingival scaling + Root scaling and plan-
ning in the treatment group (n= 179) Vs. Non treatment 
in the control group (n=103). The forest plot (Fig. 3b) 
shows a leukocytes mean difference of 0.79 g/l and a p 
value = <0.001 (95% CI: 0.717 to 0.879, heterogeneity I2 
=0%, P=0.484).
Discussion
A 2017 Cochrane systematic review of randomized 
clinical trials conducted among patients with periodon-
tal disease and ACVD antecedents (secondary preven-
tion) or patients with periodontal disease but without 
ACVD antecedents (primary prevention), failed to find 
sufficient evidence to support or refute the possibility 
that periodontal treatment prevents or delays the recur-
rence of ACVD; no evidence for primary prevention of 
ACVD was found. However, this review only included 
a single clinical trial, in which part of the control group 
received non-surgical periodontal treatment outside the 
study within the follow-up period (28).
In the works analyzed in the present literature review, 
most of the studies that analyzed CRP levels after peri-
odontal treatment (18,21,23-27) observed statistically 
significant reductions in this parameter with two excep-
tions (19,20). The periodontal treatment applied was the 
same in all six studies, but the different outcomes could 
be explained by the fact that in one work were included 
patients with advanced chronic gingivitis rather than 
severe chronic periodontitis, and that baseline values 
were significantly different between the intervention 
and control groups (20). In another clinical trial, control 
group patients were permitted to undergo periodontal 
treatment independently of the study, so that the real 
periodontal attention received by these patients was un-
known, a factor that could exert some influence in the 
absence of differences in periodontal status between the 
groups after treatment (19).    
In two trials conducted with samples of 39 (21) and 75 
(24) subjects with follow-ups of 2 and 3 months respec-
tively, the intervention groups underwent mechanical 
rather than surgical debridement, obtaining statistically 
significant reductions (p<0.05) in TFN-α values after 
periodontal treatment. But a study that applied the same 
treatment to a sample of 20 patients with a 1-month 
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Fig. 3. (a) Forest plot of studies evaluating leukocytes values before and after the administration of Oral hygiene instructions + Supragingival 
scaling + Root scaling and planning in the treatment group vs. Oral hygiene instructions in the control group.
(b)  Forest plot of studies evaluating leukocytes values before and after the administration of Oral hygiene instructions + Supragingival scaling 
+ Root scaling and planning in the treatment group vs. Non treatment.
follow-up, did not observe significant changes (p>0.05) 
in this parameter (27). This could be due to the small 
sample size or the brief follow-up period. 
Two of the works that studied IL-6 obtained significant 
reductions (p<0.05) in levels after periodontal treat-
ment (18,24). So, it may be deduced that mechanical 
debridement reduces serum levels of this soluble pro-
tein in this type of patient. The same did not occur 
with IL-1ß, registered in a sample of 37 patients with a 
12-month follow-up (19). However, this study obtained 
values proceeding from crevicular fluid, which were not 
correlated to serum levels.  
Mechanical debridement of periodontal tissues would 
appear unrelated to improvements in total cholesterol, 
HDL-C and triglyceride levels, as none of the three tri-
als (18,20,24) that analyzed these parameters observed 
significant changes (p>0.05). Nevertheless, it seems that 
periodontal treatment could be related to LDL, VLDL 
and oxidized LDL levels, as these values decreased 
significantly in three works (p<0.05, p<0.05, p<0.01 
respectively) (20,24,26). If these parameters can be im-
proved by periodontal treatment, this could constitute a 
valuable means of ACVD prevention, as these are some 
of the main components of atheromatous plaque (6).
Improving periodontal status could also be associated 
with a reduction in total leukocytes. Half of the trials 
that analyzed this parameter obtained significant reduc-
tions (p<0.05) in values (23,24,27), although the other 
three studies that looked into this parameter (20,24,26) 
did not observe significant changes. Studies with fol-
low-up periods of 1 or 2 months observed significant 
changes (23,25,27), while the others had longer follow-
up periods. This suggests that perhaps leukocyte lev-
els only respond to periodontal treatment for a limited 
period. These results coincide with the meta-analysis 
performed where a significant difference was found 
when oral hygiene instructions + supragingival scaling 
+ root scaling and planning were applied compared to 
non-treatment.
Fibrinogen levels appear to act similarly, as significant 
reductions (p<0.05) were observed in two trials with 
shorter follow-up periods of between 1 and 2 months 
after periodontal treatment (23,25). But in a study with 
a 3-month follow-up (in which no intermediate mea-
surements were performed) no changes were produced 
(26). This could be explained by the possibility that fi-
brinogen responded to mechanical debridement for a 
brief period, or perhaps due to reductions in gingival 
bleeding after treatment.  
Glycemia was analyzed in two works (18,24) with fol-
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low-up periods of 6 and 3 months respectively. Neither 
of these observed significant reductions in glycemia 
(p>0.05) after periodontal treatment, which could be 
due to this parameter’s poor response to mechanical 
debridement or to improvements in periodontal status, 
or to the possibility that the effect only continued for a 
limited period. The first of these two studies also regis-
tered insulin levels with the same results. 
Nor was periodontal treatment seen to reduce plasma 
chitotriosidase or salivary proteins, although salivary 
chitotriosidase levels were reduced (p=0.005) (22). Im-
provements in periodontal status could be associated 
with the reestablishment of some salivary parameters, 
which do not extend to systemic improvement. 
Mechanical debridement did not appear to have any 
effect on von Willebrand factor or on fibrin D-dimer, 
although further trials are necessary to confirm this, as 
the present review only found a single study that inves-
tigated these parameters (26).
Blood flow response to acetylcholine increased consid-
erably (p<0.001) after periodontal treatment, improving 
the endothelial dysfunction typical of periodontal pa-
tients (18). However, no changes in malondialdehyde-
modified LDL, 8-hydroxy-2’-deoxyguanosine, or fore-
arm blood flow response to sodium nitroprusside were 
observed. As this analysis took place at the end of a 
6-month follow-up, there could have been some short-
term improvement that was not registered. 
Only two of the works reviewed considered non-analytic 
parameters (18,20), and the only parameter to show a sta-
tistically significant improvement (p<0.05) was systolic 
blood pressure (20). Further studies with longer follow-
up periods would be needed to determine whether peri-
odontal treatment improves clinical parameters of car-
diovascular patients beyond the biochemical parameters 
analyzed in most of the trials conducted to date.   
In agreement with the findings of the present review, 
a meta-analysis published in 2014 concluded that peri-
odontal treatment improves endothelial function and 
the atherosclerotic profile of periodontal patients with 
ACVD and/or diabetes (29). Similarly, an earlier 2013 
systematic review affirmed that periodontal treatment 
produces a progressive reduction in systemic inflamma-
tion and improvements in endothelial function. How-
ever, there is no evidence that these changes have any 
long-term effect on cardiovascular risk in patients with 
periodontitis (3).
Lastly, another meta-analysis that focused on CRP val-
ues alone concluded that non-surgical periodontal treat-
ment reduced serum levels of this protein (30). This 
agrees with the results obtained in the meta-analysis 
performed in the present review, where a decreased 
in CRP values was noted to be statistically significant 
when patients were submitted to non-surgical periodon-
tal treatment in contrast to receiving no treatment at all.
Even the positive results obtained, considering the limi-
tations discussed throughout the study, more homoge-
neous clinical trials, with larger samples, more detailed 
methodology and longer follow-up periods are needed 
in order to generalize these findings.
In conclusion, periodontal treatment can improve some 
biochemical parameters involved in the development of 
ACVD, including CRP, TNF-α, IL-6, fibrinogen, leuko-
cytes, oxidized LDL, and VLDL-C. The non-analytic 
parameters investigated did not respond to periodontal 
treatment. Further clinical studies with longer follow-
up periods and regular periodic analyses are necessary 
to establish the effect of non-surgical periodontal treat-
ment on patients with ACVD. 
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